findmyKOL
Clinical trialNCT06707493RecruitingPhase 2Interventional

Ivosidenib as Post-HSCT Maintenance for AML

SponsorMassachusetts General HospitalEnrollment75Acute Myeloid Leukemia (AML)Hematopoietic Stem Cell Transplant (HSCT)IDH1 Mutation
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Emory University Hospital

    Atlanta, Georgia, United States

    Amelia Langston, MD
    Recruiting
  • Dana Farber Cancer Institute

    Boston, Massachusetts, United States

    Robert Soiffer, MD
    Recruiting
  • Massachusetts General Hospital

    Boston, Massachusetts, United States

    Amir Fathi, MD
    Recruiting
  • Ohio State University Wexner Medical Center- James Cancer Hospital

    Columbus, Ohio, United States

    Jiasheng Wang, MD
    Recruiting
  • Huntsman Cancer Institute, University of Utah

    Salt Lake City, Utah, United States

    Sagar Patel, MD
    Recruiting
  • Froedtert Hospital & the Medical College of Wisconsin

    Milwaukee, Wisconsin, United States

    Sameem Abedin, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
16 Jan 2026
Primary completion
1 Jan 2028
Completion
1 Jan 2030
Last update posted
18 Jun 2026
Registered enrollment
75
Registry id
NCT06707493
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.